Govt panel recommends market authorisation for Covovax jab

Govt panel recommends market authorisation for Covovax jab as heterologous booster dose

Back To Homepage Subscribe To RSS Feed

Breaking News

Two women die, six in critical condition after consuming mango kernel dishes in Odisha Bhubaneswar, Nov. 1: Two women have died, and six others are in critical condition after allegedly consuming dishes made from mango kernels in Odisha’s Kandhamal district. The incident occurred in...
Odisha government imposes seven-month fishing ban to protect Olive Ridley turtles in Gahirmatha Bhubaneswar, Nov. 1: In a move to protect the endangered Olive Ridley sea turtles, Odisha’s government has implemented a seven-month fishing ban in the Gahirmatha Marine Sanctuary, spanning 1,437 square...
Ramachandra Khuntia leads race for OPCC chief post as Congress eyes fresh leadership in Odisha By A.K. Sahoo Bhubaneswar, Nov. 1: With the Odisha Pradesh Congress Committee (OPCC) chief post vacant following Sarat Pattanayak’s resignation, the search for a new leader has sparked intense interest...
Posco-JSW to establish major steel plant in Keonjhar: CM Mohan Majhi By Nalini Sahu Bhubaneswar, Nov. 1: In a landmark move for Odisha’s industrial landscape, South Korean steel giant Posco and India’s JSW Steel, led by Sajjan Jindal, have announced a...
Eminent Feminist Writer Sarojini Sahoo Receives Prestigious Sarala Puraskar By Priya Mohapatra Bhubaneswar, Oct. 31: Celebrated feminist author Sarojini Sahoo has been awarded the prestigious Sarala Puraskar for 2024, Odisha’s foremost literary honor established by the Indian Metals Public...

Govt panel recommends market authorisation for Covovax jab as heterologous booster dose

January 12

19:19 2023

Print This Article Share it With Friends

by indadmin

NEW DELHI, JAN 12: An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Thursday.

Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs Controller General of India (DCGI) for approval of Covovax heterologous booster dose for those aged 18 years and above in view of escalating covid-19 pandemic situation in some countries, the sources said.

“The subject expert committee (SEC) of the CDSCO on Wednesday deliberated on the issue and recommended for market authorisation of Covid jab Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin,” an official source said.

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022 and also in children aged 7-11 years on June 28, 2022 subject to certain conditions.

Covovax is manufactured through technology transfer from Novavax. It has been approved by the European Medicines Agency for conditional marketing authorization.

It was granted emergency-use listing by the World Health Organization (WHO) on December 17, 2021. In August 2020, US-based vaccine maker Novavax Inc. had announced a licence agreement with SII for development and commercialization of NVX-CoV2373, its ocvid-19 vaccine candidate in India and low-and-middle-income countries.

-PTI